<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html xml:lang="en" lang="en" xmlns="http://www.w3.org/1999/xhtml"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta name="ROBOTS" content="NOARCHIVE" /><meta name="googlebot" content="nosnippet" /><meta name="Document-Type" content="int-interactant" /><meta name="keywords" content="" /><title>Alcohol: British National Formulary</title><link type="text/css" rel="stylesheet" href="../../theme/theme.css" /><link type="text/css" rel="stylesheet" href="../../theme/print.css" media="print" /><link type="text/css" rel="stylesheet" href="265/style.css" /><link type="image/x-icon" rel="shortcut icon" href="favicon.ico" /><link rel="stylesheet" type="text/css" href="style/screen.css" media="screen" /><link rel="stylesheet" type="text/css" href="style/print.css" media="print" /><link rel="contents" type="text/html" href="index.htm" /><link rel="help" type="text/html" href="http://www.medicinescomplete.com/mc/help_page.htm" /><link rel="start" type="text/html" href="index.htm" title="British National Formulary" /><link rel="copyright" type="text/html" href="35091.htm" title="Copyright information" /><link rel="bookmark" title="Skip Navigation" href="41001i20.htm#pB" /><script type="text/javascript" src="https://ajax.googleapis.com/ajax/libs/jquery/1.7.0/jquery.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.tooltip.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.cookie.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.autosuggest.js"></script><script type="text/javascript" src="../../scripts/scripts.js"></script><style type="text/css">
  .contentsbox { position: fixed; z-index:1001;}
  .contentsbox_wrap {overflow:hidden;width:20px;height:130px; position:absolute;left:0;top:0;}
</style><!--[if lte IE 7]>
          <style type="text/css">
          .contentsbox {
          position: absolute;
          left: expression( ( 15 + ( ignoreMe2 = document.documentElement.scrollLeft ? document.documentElement.scrollLeft : document.body.scrollLeft ) ) + 'px' );
          top: expression( ( 250 + ( ignoreMe = document.documentElement.scrollTop ? document.documentElement.scrollTop : document.body.scrollTop) ) + 'px' );
          }
          .threecol_col3 {
          font-family: arial
          }
          .threecol_col3 a {
          font-family: verdana,helvetica,sans-serif
          }
          .threecol_col1 {
          font-family: arial
          }
          .threecol_col1 a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pE {
          font-family: arial
          }
          div#pE a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pK {
          font-family: arial
          }
          div#pK a {
          font-family: verdana,helvetica,sans-serif
          }
          </style>
          <![endif]--></head><body><?highlighter off?><div id="pU"><a id="pD" accesskey="s" rel="bookmark" href="41001i20.htm#pB" title="Skip Navigation">Skip Navigation</a><ul id="pZ"><li><a href="http://www.medicinescomplete.com/mc/account.htm">You are signed in as a member of <b>BNF.org Free Access</b></a></li><li> | <a href="http://www.medicinescomplete.com/mc/login.htm">Sign in different user</a></li><li> | <a href="http://www.medicinescomplete.com/mc/logout.htm">Sign out</a></li></ul><a href="http://www.medicinescomplete.com/mc/" title="Go to the MedicinesComplete home page"><img src="../../images/mc.png" alt="MedicinesComplete" /></a><ul id="pM"><li><a href="http://www.medicinescomplete.com/mc/" class="selected" accesskey="1" title="Home: access key 1"><strong><span>Home</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/"><strong><span>Welcome</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/feedback.htm?pub=bnf&amp;uri=41001i20.htm" accesskey="9" title="Feedback: access key 9"><strong><span>Feedback</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/help.htm" accesskey="6" title="Help button: access key 6"><strong><span>Help</span></strong></a></li></ul></div><div id="pA"><div id="pY">British National Formulary</div><div id="pG">Printed from: Joint Formulary Committee.  <i>British National Formulary</i>. [online] London: BMJ Group and Pharmaceutical Press.. &lt; http://www.medicinescomplete.com/ &gt; [Accessed on 26 May 2012 (GMT)].</div><div id="pQ"><form id="searchForm" method="get" action="http://www.medicinescomplete.com/mc/bnf/current/search.htm"><fieldset><legend>Details</legend><label for="q">Search for</label><div id="qd"><div><input accesskey="4" type="text" id="q" name="q" /><input class="button" id="searchButton" type="submit" value="Search" name="searchButton" title="Search full text" /></div></div></fieldset></form><script type="text/javascript">$(document).ready(function(){$("#q").autoSuggest('http://www.medicinescomplete.com/mc/bnf/current/search/suggest.xml', {control: "#searchButton"});});</script></div></div><div id="pH"><div id="pN"><div id="pT"><span class="cA"><a href="http://www.medicinescomplete.com/mc/">Home</a></span> &gt; <a href="index.htm">BNF No. 63 (March 2012)</a> &gt; <a href="41001.htm">Appendix 1 Interactions</a> &gt; <a href="53178.htm">List of drug interactions</a></div><div id="pP"><div class="threecol_col1">◄ <a accesskey="[" href="41001i1012.htm" title="Previous: Agalsidase Alfa and Beta">Previous page</a></div><div class="threecol_col2"> </div><div class="threecol_col3"><a accesskey="]" href="41001i21.htm" title="Next: Aldesleukin">Next page</a> ►</div></div></div></div><div id="p1"><div id="pB"><h1 id="_41001i20">Alcohol</h1><div id="pC" class="jN"><p class="int-specific-drug-name"><b>Alcohol</b>
          has the following interaction information:
        </p><table summary="Drug interactions" width="100%" border="0" cellspacing="2"><colgroup><col width="30%" class="cBT" /><col width="40%" class="cBS" /><col width="30%" class="cBU" /></colgroup><tbody><tr><td><a href="41001i2.htm" name="_2">ACE Inhibitors</a></td><td>enhanced hypotensive effect when  alcohol given with ACE inhibitors </td><td></td></tr><tr><td><a href="41001i683.htm">Acitretin</a></td><td class="cBV"><b>presence of  alcohol causes etretinate to be formed from acitretin (increased risk of teratogenecity in women of child-bearing potential)</b></td><td></td></tr><tr><td><a href="41001i15.htm" name="_15">Adrenergic Neurone Blockers</a></td><td>enhanced hypotensive effect when  alcohol given with adrenergic neurone blockers </td><td></td></tr><tr><td><a href="41001i26.htm" name="_26">Alpha-blockers</a></td><td>enhanced hypotensive effect when  alcohol given with alpha-blockers </td><td></td></tr><tr><td><a href="41001i107.htm" name="_107">Angiotensin-II Receptor Antagonists</a></td><td>enhanced hypotensive effect when  alcohol given with angiotensin-II receptor antagonists </td><td></td></tr><tr><td><a href="41001i232.htm">Antidepressants, SSRI</a></td><td>sedative effects possibly increased when  alcohol given with SSRIs </td><td></td></tr><tr><td><a href="41001i241.htm" name="_241">Antidepressants, Tricyclic</a></td><td class="cBV"><b>increased sedative effect when  alcohol given with tricyclics </b></td><td></td></tr><tr><td><a href="41001i252.htm" name="_252">Antidepressants, Tricyclic (related)</a></td><td class="cBV"><b>increased sedative effect when  alcohol given with tricyclic-related antidepressants </b></td><td></td></tr><tr><td><a href="41001i264.htm" name="_264">Antidiabetics</a></td><td> alcohol enhances hypoglycaemic effect of antidiabetics </td><td></td></tr><tr><td><a href="41001i303.htm" name="_303">Antihistamines</a></td><td>increased sedative effect when  alcohol given with antihistamines (possibly less effect with non-sedating antihistamines)</td><td>Sedative interactions apply to a lesser extent to the non-sedating antihistamines. Interactions do not generally apply to antihistamines used for topical action (including inhalation)</td></tr><tr><td><a href="41001i363.htm">Antipsychotics</a></td><td>increased sedative effect when  alcohol given with antipsychotics </td><td>Increased risk of toxicity with myelosuppressive drugs</td></tr><tr><td><a href="41001i404.htm">Anxiolytics and Hypnotics</a></td><td>increased sedative effect when  alcohol given with anxiolytics and hypnotics </td><td></td></tr><tr><td><a href="41001i617.htm">Baclofen</a></td><td>increased sedative effect when  alcohol given with baclofen </td><td></td></tr><tr><td><a href="41001i440.htm" name="_440">Beta-blockers</a></td><td>enhanced hypotensive effect when  alcohol given with beta-blockers </td><td>Since systemic absorption may follow topical application of beta-blockers to the eye the possibility of interactions, in particular, with drugs such as verapamil should be borne in mind</td></tr><tr><td><a href="41001i556.htm" name="_556">Bromocriptine</a></td><td> alcohol reduces tolerance to bromocriptine </td><td></td></tr><tr><td><a href="41001i466.htm" name="_466">Calcium-channel Blockers</a></td><td>enhanced hypotensive effect when  alcohol given with calcium-channel blockers </td><td>Dihydropyridine calcium-channel blockers include amlodipine, felodipine, isradipine, lacidipine, lercanidipine, nicardipine, nifedipine, and nimodipine</td></tr><tr><td><a href="41001i277.htm" name="_277">Carbamazepine</a></td><td> alcohol possibly increases CNS side-effects of carbamazepine </td><td></td></tr><tr><td><a href="41001i482.htm" name="_482">Clonidine</a></td><td>enhanced hypotensive effect when  alcohol given with clonidine </td><td></td></tr><tr><td><a href="41001i220.htm">Coumarins</a></td><td class="cBV"><b>major changes in consumption of  alcohol may affect anticoagulant control with coumarins </b></td><td>Change in patient’s clinical condition, particularly associated with liver disease, intercurrent illness, or drug administration, necessitates more frequent testing. Major changes in diet (especially involving salads and vegetables) and in alcohol consumption may also affect anticoagulant control</td></tr><tr><td><a href="41001i160.htm">Cycloserine</a></td><td class="cBV"><b>increased risk of convulsions when  alcohol given with cycloserine </b></td><td></td></tr><tr><td><a href="41001i522.htm" name="_522">Diazoxide</a></td><td>enhanced hypotensive effect when  alcohol given with diazoxide </td><td></td></tr><tr><td><a href="41001i523.htm" name="_523">Disulfiram</a></td><td>disulfiram reaction when  alcohol given with disulfiram (see <a title="Disulfiram (monograph-family)" href="213763.htm#_213763">section 4.10.1</a>)</td><td></td></tr><tr><td><a href="41001i524.htm" name="_524">Diuretics</a></td><td>enhanced hypotensive effect when  alcohol given with diuretics </td><td></td></tr><tr><td><a href="41001i291.htm">Griseofulvin</a></td><td>effects of  alcohol possibly enhanced by griseofulvin </td><td></td></tr><tr><td><a href="41001i763.htm" name="_763">Hydralazine</a></td><td>enhanced hypotensive effect when  alcohol given with hydralazine </td><td></td></tr><tr><td><a href="41001i346.htm">Hyoscine</a></td><td>increased sedative effect when  alcohol given with hyoscine </td><td></td></tr><tr><td><a href="41001i28.htm">Indoramin</a></td><td>increased sedative effect when  alcohol given with indoramin </td><td></td></tr><tr><td><a href="41001i1032.htm" name="_1032">Levamisole</a></td><td>possibility of disulfiram-like reaction when  alcohol given with levamisole </td><td></td></tr><tr><td><a href="41001i607.htm" name="_607">Lofexidine</a></td><td>increased sedative effect when  alcohol given with lofexidine </td><td></td></tr><tr><td><a href="41001i257.htm">MAOIs</a></td><td class="cBV"><b>some beverages containing  alcohol and some dealcoholised beverages contain tyramine which interacts with MAOIs (hypertensive crisis)—if no tyramine, enhanced hypotensive effect</b></td><td>For interactions of reversible MAO-A inhibitors (RIMAs) see Moclobemide, and for interactions of MAO-B inhibitors see Rasagiline and Selegiline; the antibacterial Linezolid is a reversible, non-selective MAO inhibitor</td></tr><tr><td><a href="41001i267.htm">Metformin</a></td><td>increased risk of lactic acidosis when  alcohol given with metformin </td><td></td></tr><tr><td><a href="41001i619.htm">Methocarbamol</a></td><td>increased sedative effect when  alcohol given with methocarbamol </td><td></td></tr><tr><td><a href="41001i611.htm" name="_611">Methyldopa</a></td><td>enhanced hypotensive effect when  alcohol given with methyldopa </td><td></td></tr><tr><td><a href="41001i718.htm" name="_718">Methylphenidate</a></td><td> alcohol possibly enhances effects of methylphenidate </td><td></td></tr><tr><td><a href="41001i613.htm">Metoclopramide</a></td><td>absorption of  alcohol possibly increased by metoclopramide </td><td></td></tr><tr><td><a href="41001i170.htm">Metronidazole</a></td><td>disulfiram-like reaction when  alcohol given with metronidazole </td><td>Interactions do not apply to topical metronidazole preparations </td></tr><tr><td><a href="41001i764.htm" name="_764">Minoxidil</a></td><td>enhanced hypotensive effect when  alcohol given with minoxidil </td><td></td></tr><tr><td><a href="41001i823.htm" name="_823">Mirtazapine</a></td><td class="cBV"><b>increased sedative effect when  alcohol given with mirtazapine </b></td><td></td></tr><tr><td><a href="41001i615.htm" name="_615">Moxonidine</a></td><td>enhanced hypotensive effect when  alcohol given with moxonidine </td><td></td></tr><tr><td><a href="41001i630.htm" name="_630">Nicorandil</a></td><td> alcohol possibly enhances hypotensive effect of nicorandil </td><td></td></tr><tr><td><a href="41001i631.htm" name="_631">Nitrates</a></td><td>enhanced hypotensive effect when  alcohol given with nitrates </td><td></td></tr><tr><td><a href="41001i85.htm" name="_85">Opioid Analgesics</a></td><td>enhanced hypotensive and sedative effects when  alcohol given with opioid analgesics </td><td></td></tr><tr><td><a href="41001i871.htm">Paraldehyde</a></td><td class="cBV"><b>increased sedative effect when  alcohol given with paraldehyde </b></td><td></td></tr><tr><td><a href="41001i223.htm">Phenindione</a></td><td class="cBV"><b>major changes in consumption of  alcohol may affect anticoagulant control with phenindione </b></td><td>Change in patient’s clinical condition particularly associated with liver disease, intercurrent illness, or drug administration, necessitates more frequent testing. Major changes in diet (especially involving salads and vegetables) and in alcohol consumption may also affect anticoagulant control  </td></tr><tr><td><a href="41001i437.htm" name="_437">Phenobarbital</a></td><td>increased sedative effect when  alcohol given with phenobarbital </td><td></td></tr><tr><td><a href="41001i284.htm" name="_284">Phenytoin</a></td><td>chronic heavy consumption of  alcohol possibly reduces plasma concentration of phenytoin </td><td></td></tr><tr><td><a href="41001i514.htm">Procarbazine</a></td><td>disulfiram-like reaction when  alcohol given with procarbazine </td><td></td></tr><tr><td><a href="41001i1195.htm" name="_1195">Retigabine</a></td><td>increased risk of blurred vision when  alcohol given with retigabine </td><td></td></tr><tr><td><a href="41001i765.htm" name="_765">Sodium Nitroprusside</a></td><td>enhanced hypotensive effect when  alcohol given with sodium nitroprusside </td><td></td></tr><tr><td><a href="41001i786.htm">Tinidazole</a></td><td>possibility of disulfiram-like reaction when  alcohol given with tinidazole </td><td></td></tr><tr><td><a href="41001i805.htm" name="_805">Tizanidine</a></td><td>increased sedative effect when  alcohol given with tizanidine </td><td></td></tr><tr><td><a href="41001i467.htm">Verapamil</a></td><td>plasma concentration of  alcohol possibly increased by verapamil </td><td></td></tr></tbody></table></div><?highlighter on?><?highlighter off?><div id="pE">◄ <a accesskey="[" href="41001i1012.htm">Previous: Agalsidase Alfa and Beta</a> | <a class="top" href="41001i20.htm#">Top</a> | <a accesskey="]" href="41001i21.htm">Next: Aldesleukin</a> ►</div></div></div><div id="pF"><div id="pL"><div id="footer"><div id="footerinner"><ul><li><a accesskey="0" href="accessibility.htm" title="Accessibility information: access key 0">Accessibility</a> | </li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/contact.htm">Contact Us</a> | </li><li><a href="privacy.htm" title="Privacy Policy">Privacy Policy</a> | </li><li><a accesskey="3" href="http://www.medicinescomplete.com/mc/sitemap.htm" title="Site Map: access key 3">Site Map</a> | </li><li><a accesskey="8" href="terms.htm" title="Terms and Conditions: access key 8">Terms and Conditions</a></li></ul></div></div></div><div id="pX"><p><a href="35091.htm" rel="copyright">Copyright © BMJ Group and the Royal Pharmaceutical Society of Great Britain 2012. All rights reserved.</a></p></div></div><script type="text/javascript">$(document).ready(function(){$.ga('UA-9959526-1');});</script></body></html>